Oncolytic Biotechnology


Oncolytic Biotechnology is the study of oncolytic virus, the virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumour. Oncolytic viruses are thought not only to cause direct destruction of the tumour cells, but also to stimulate host anti-tumour immune responses.


    Related Conference of Oncolytic Biotechnology

    July 11-12, 2022

    "18th World Congress on Structural Biology"

    Paris, France
    July 11-12, 2022

    3rd International Conference on Drug Chemistry

    Singapore City, Singapore
    August 24-25, 2022

    2nd International Conference on Biotechnology

    London, UK
    August 29-30, 2022

    14th World Congress on Cell & Tissue Science

    Stockholm, Sweden
    August 31-01, 2022

    2nd International Conference on Glycomics and Proteomics

    Stockholm, Sweden
    September 05-06, 2022

    4th International Conference on Biomarkers and Cell Biology

    Barcelona, Spain
    September 12-13, 2022

    23rd Global Summit on Analytical and Bioanalytical Techniques

    Prague, Czech Republic
    September 26-27, 2022

    International Bio Summit and Expo

    Brussels, Belgium
    September 26-27, 2022

    26th European Biotechnology Congress

    Paris, France
    October 24-25, 2022

    5th International Conference on Glycobiology

    Paris, France
    November 14-15, 2022

    4th International Conference on Biochemistry

    London, UK
    November 14-15, 2022

    4th International Conference on Nucleic Acids

    London, UK

    Oncolytic Biotechnology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in